This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1981 Aug 29;2(8244):478.

doi: 10.1016/s0140-6736(81)90817-5.

Lowered HDL cholesterol and incidence of ischaemic heart disease

T A Miettinen, J K Huttunen, T Strandberg, V Naukkarinen, S Mattila, T Kumlin

PMID: 6115240
DOI: 10.1016/s0140-6736(81)90817-5

Lowered HDL cholesterol and incidence of ischaemic heart disease

T A Miettinen et al. Lancet. 1981.

. 1981 Aug 29;2(8244):478.

doi: 10.1016/s0140-6736(81)90817-5.

Authors

T A Miettinen, J K Huttunen, T Strandberg, V Naukkarinen, S Mattila, T Kumlin

PMID: 6115240
DOI: 10.1016/s0140-6736(81)90817-5

No abstract available

PubMed Disclaimer

Similar articles

Is it harmful to lower HDL levels?
Henahan J. Henahan J. JAMA. 1981 Nov 20;246(20):2311, 2315. JAMA. 1981. PMID: 7299948 No abstract available.
Probucol: effects on the metabolism of low density and high density lipoproteins in moderate hypercholesterolaemia.
Magill P, Whiting C, Hammett F, Glick I, Miller NE, Lewis B. Magill P, et al. Artery. 1982;10(2):88-94. Artery. 1982. PMID: 7092581
Probucol and ischaemic heart disease.
Oliver MF. Oliver MF. Lancet. 1981 Oct 10;2(8250):805. doi: 10.1016/s0140-6736(81)90208-7. Lancet. 1981. PMID: 6116924 No abstract available.
[Probucol, HDL and inverse transport of cholesterol].
[No authors listed] [No authors listed] Med Clin (Barc). 1989 Oct 28;93(13):22-3 p.. Med Clin (Barc). 1989. PMID: 2695695 Review. Spanish. No abstract available.
[Pharmacology of probucol. II].
Donatelli L. Donatelli L. Clin Ter. 1984 Mar 31;108(6):475-95. Clin Ter. 1984. PMID: 6233067 Review. Italian. No abstract available.

See all similar articles

Cited by

Hypolipidemic activity of o-(N-phthalimido)acetophenone in Sprague Dawley rats.
Hall IH, Reynolds DJ, Wong OT, Oswald CB, Murthy AR. Hall IH, et al. Pharm Res. 1987 Dec;4(6):472-9. doi: 10.1023/a:1016471320566. Pharm Res. 1987. PMID: 3508559
Hypolipidemic activity of 3- and 4-phenyl-piperidine-2,6-diones and selected N-substituted derivatives.
Murthy AR, Maguire JH, Alphin RS, Day PA, Hall IH. Murthy AR, et al. Lipids. 1986 Oct;21(10):617-22. doi: 10.1007/BF02537209. Lipids. 1986. PMID: 3796228
Hypolipidemic activity of 6-alkoxycarbonyl-3-aryl-1,3,5- triazabicyclo[3.1.0]hexane-2,4-diones and 2-alkoxycarbonyl-5-aryl-1,3,5-triazine-4,6(1H,5H)-diones in rodents.
Izydore RA, Wong OT, Hall IH. Izydore RA, et al. Lipids. 1993 Mar;28(3):223-9. doi: 10.1007/BF02536643. Lipids. 1993. PMID: 8464353
HDL cholesterol and beta-adrenoceptor blocking agents in a 5 year multifactorial primary prevention trial.
Miettinen TA, Vanhanen H, Huttunen JK, Naukkarinen V, Mattila S, Strandberg T, Kumlin T. Miettinen TA, et al. Br J Clin Pharmacol. 1982;13(Suppl 2):431S-434S. doi: 10.1111/j.1365-2125.1982.tb01952.x. Br J Clin Pharmacol. 1982. PMID: 6125196 Free PMC article.
Effects of 2-(2,4-dimethylphenyl)indan-1,3-dione on serum lipoprotein and lipid metabolism of rodents.
Hall IH, Murthy AR, Day PA, Clavin J. Hall IH, et al. Lipids. 1988 Aug;23(8):755-60. doi: 10.1007/BF02536217. Lipids. 1988. PMID: 3185107

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information